Asembia AXS25 Summit: Experts Address High Costs of Rare Disease Therapies

Experts at the recent Asembia AXS25 Summit focused on the financial aspects of specialty pharmacies that serve patients with rare diseases, specifically discussing the high costs of therapies and approaches to support continued medical advancements. The discussions centered on the economic challenges inherent in providing specialized pharmaceutical services for rare diseases. These challenges include the considerable expense associated with developing and delivering treatments. The summit participants examined various strategies designed to find equilibrium between fostering innovation in the pharmaceutical sector and managing the financial burdens that impact patients, healthcare systems, and specialty pharmacies.

Newsflash | Powered by GeneOnline AI
Date: April 29, 2025

Author

Mark Chiang